Evotec SE (EVO) Discusses Horizon Initiative as Next Phase in Strategic Transformation for Operational Excellence and Growth Transcript
Source: SeekingAlpha
2026-03-10 18:30:20 ET
Evotec SE (EVO) Discusses Horizon Initiative as Next Phase in Strategic Transformation for Operational Excellence and Growth March 10, 2026 10:00 AM EDT...
Read the full article on Seeking Alpha
For further details see:
Evotec SE (EVO) Discusses Horizon Initiative as Next Phase in Strategic Transformation for Operational Excellence and Growth Transcript
Evotec SE
NASDAQ: EVOTF
EVOTF Trading
177900.0% G/L:
$8.01 Last:
2,814 Volume:
$8.01 Open:
EVOTF Latest News
January 08, 2026 01:50:00 am
Just - Evotec Biologics Receives Grant for AI-Driven Optimization of Monoclonal Antibody Developability for Affordable Access
January 02, 2026 12:30:00 am
Evotec Appoints Dr. Sarah Fakih as EVP, Head of Global Communications and Investor Relations
December 08, 2025 01:20:00 am
Evotec Closes Sale of Just - Evotec Biologics' Toulouse Site to Sandoz
December 04, 2025 02:50:00 am
Evotec-Partner Bayer Starts Phase 2 Study for Treatment of Patients with Alport Syndrome
EVOTF Stock Data
$326,390,317
157,381,715
N/A
374
N/A
Biotechnology & Life Sciences
Healthcare
DE
Hamburg
